| Prospects on the use of Schizochytrium sp. to develop oral vaccines A Ramos-Vega, S Rosales-Mendoza, B Bañuelos-Hernández, C Angulo Frontiers in Microbiology 9, 353095, 2018 | 39 | 2018 |
| Microalgae-made vaccines against infectious diseases A Ramos-Vega, C Angulo, B Bañuelos-Hernández, E Monreal-Escalante Algal Research 58, 102408, 2021 | 24 | 2021 |
| Microalgae with immunomodulatory effects on fish A Bahi, A Ramos‐Vega, C Angulo, E Monreal‐Escalante, FA Guardiola Reviews in Aquaculture 15 (4), 1522-1539, 2023 | 21 | 2023 |
| Expression of the VP40 antigen from the Zaire ebolavirus in tobacco plants E Monreal-Escalante, AA Ramos-Vega, JA Salazar-González, ... Planta 246, 123-132, 2017 | 19 | 2017 |
| Plant-based vaccines: Antigen Design, Diversity, and strategies for high Level production E Monreal-Escalante, A Ramos-Vega, C Angulo, B Bañuelos-Hernández Vaccines 10 (1), 100, 2022 | 15 | 2022 |
| Plant-made vaccines against parasites: bioinspired perspectives to fight against Chagas disease A Ramos-Vega, E Monreal-Escalante, E Dumonteil, ... Expert Review of Vaccines 20 (11), 1373-1388, 2021 | 9 | 2021 |
| Trypanosoma cruzi Tc24 Antigen Expressed and Orally Delivered by Schizochytrium sp. Microalga is Immunogenic in Mice A Ramos-Vega, E Monreal-Escalante, S Rosales-Mendoza, ... Molecular Biotechnology, 1-13, 2023 | 4 | 2023 |
| Probiotic Debaryomyces hansenii CBS 8339 yeast enhanced immune responses in mice M Angulo, A Ramos, M Reyes-Becerril, K Guerra, E Monreal-Escalante, ... 3 Biotech 13 (1), 28, 2023 | 3 | 2023 |
| Genetic-engineered Schizochytrium sp. expressing a multiepitopic protein based on Vibrio parahaemolyticus toxins triggers immune responses in mice E Trujillo, R Villegas-Zagal, A Ramos-Vega, B Bañuelos-Hernández, ... Algal Research 79, 103440, 2024 | 1 | 2024 |
| Macroalgae: Marine players in vaccinology E Trujillo, E Monreal-Escalante, A Ramos-Vega, C Angulo Algal Research, 103392, 2024 | 1 | 2024 |
| Protective efficacy of the oral vaccine Tc24: Co1 produced in Schizochytrium sp. against Trypanosoma cruzi infection in a mouse model A Ramos-Vega, VM Dzul-Huchim, LE Villanueva-Lizama, E Dumonteil, ... Microbial Pathogenesis 186, 106488, 2024 | 1 | 2024 |
| Potential assessment of probiotic Cystobasidium benthicum LR192 strain in mice M Angulo, K Guerra, A Ramos, E Monreal-Escalante, E Martínez, ... Archives of Microbiology 204 (12), 729, 2022 | 1 | 2022 |
| Desarrollo de una vacuna oral dirigida a células M, basada en el antígeno Tc24 de Trypanosoma cruzi y el ligando Co1, utilizando Schizochytrium sp. como plataforma de … AA Ramos Vega Centro de Investigaciones Biológicas del Noroeste, SC, 2023 | | 2023 |
| Rumbo al desarrollo de una vacuna de bajo costo contra la enfermedad de Chagas AAR Vega, EM Escalante, CEA Valadez Recursos Naturales y Sociedad, 2020 | | 2020 |
| Plantas como biofábricas de vacunas orales para animales CEA VALADEZ, PC GARCIA, BM MARQUEZ, CFS ROBLEDO, ... Centro de Investigaciones Biológicas del Noroeste, SC, 2016 | | 2016 |
| Producción del antígeno MAP 1609c de Mycobacterium avium subsp. paratuberculosis en Schizochytrium sp. y evaluación del efecto inmunoestimulante de la microalga en modelo de ratón. AA Ramos Vega Centro de Investigaciones Biológicas del Noroeste, SC, 2016 | | 2016 |
